JPM vs PFD
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
PFD presents as a stable income vehicle with a Piotroski F-Score of 5/9, indicating stable financial health. While the Graham Number of $16.53 suggests significant defensive undervaluation and the Price/Book ratio of 0.93 confirms the stock is trading below its asset value, this is offset by negative earnings growth (-13.50%) and a bearish technical trend. The fund is effectively a value play for income seekers rather than a growth investment, as evidenced by the stark contrast between its Graham value and its growth-based intrinsic value of $6.72.
Compare Another Pair
Related Comparisons
JPM vs PFD: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Flaherty & Crumrine Preferred Income Fund Inc. (PFD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.